Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:12-22
Published online before print November 6, 2003, doi: 10.1161/01.ATV.0000105054.43931.f0
Published online before print November 6, 2003, doi: 10.1161/01.ATV.0000105054.43931.f0
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 American Heart Association, Inc.
Brief Reviews |
Site Specificity of Atherosclerosis
Site-Selective Responses to Atherosclerotic Modulators
From the Department of Pathology, University of Chicago, Chicago, IL.
Correspondence to Godfrey S. Getz, University of Chicago, Department of Pathology MC 1089, 5841 S Maryland Ave, Chicago, IL 60637. E-mail g-getz{at}uchicago.edu
Atherosclerosis is a complex disease process that affects very specific sites of the vasculature. It is recognized that hemodynamic forces are largely responsible for dictating which vascular sites are either susceptible or resistant to developing atherosclerosis. In addition, a number of systemic and local factors also modulate the pathogenesis of the disease. By studying the development of atherosclerosis in mice, investigators have gained insights into the molecular mechanisms of this disease, although studies have largely focused on a single vascular site. Here, we review those recent studies in which vascular site-specific effects on atherosclerosis were reported when more than 1 site was examined. We assess the hypothesis that regional differences in the hemodynamic profile prime the endothelial phenotype to respond distinctly to such systemic risk factors as hypercholesterolemia, genetics, immune status, gender, and oxidative stress. Because a given treatment may differentially affect the development of atherosclerotic lesions throughout the vasculature, the sites chosen for study are critically important. By accounting for the complex interplay of factors that may operate at these different sites, a more complete understanding of the overriding mechanisms that control the initiation and progression of the atherosclerotic lesion may be realized.
Key Words: atherosclerosis • hemodynamics • risk factors • site specificity
This article has been cited by other articles:
 |
|
 |
|
  P. Chew, D. Y.C. Yuen, P. Koh, N. Stefanovic, M. A. Febbraio, I. Kola, M. E. Cooper, and J. B. de Haan Site-Specific Antiatherogenic Effect of the Antioxidant Ebselen in the Diabetic Apolipoprotein E-Deficient Mouse Arterioscler. Thromb. Vasc. Biol., June 1, 2009; 29(6): 823 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. W. Parks, R. Srivastava, S. Yu, and J. H.S. Kabarowski ApoE-Dependent Modulation of HDL and Atherosclerosis by G2A in LDL Receptor-Deficient Mice Independent of Bone Marrow-Derived Cells Arterioscler. Thromb. Vasc. Biol., April 1, 2009; 29(4): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. VanderLaan, C. A. Reardon, R. A. Thisted, and G. S. Getz VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice J. Lipid Res., March 1, 2009; 50(3): 376 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Bennett, S. S. Wang, X. Wang, X. Wu, and A. J. Lusis Genetic Regulation of Atherosclerotic Plaque Size and Morphology in the Innominate Artery of Hyperlipidemic Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2009; 29(3): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. McRobb, D. J. Handelsman, and A. K. Heather Androgen-Induced Progression of Arterial Calcification in Apolipoprotein E-Null Mice Is Uncoupled from Plaque Growth and Lipid Levels Endocrinology, February 1, 2009; 150(2): 841 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rohlena, O. L. Volger, J. D. van Buul, L. H.P. Hekking, J. M. van Gils, P. I. Bonta, R. D. Fontijn, J. A. Post, P. L. Hordijk, and A. J.G. Horrevoets Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion Cardiovasc Res, January 1, 2009; 81(1): 187 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Peng, R. A. Hiipakka, Q. Dai, J. Guo, C. A. Reardon, G. S. Getz, and S. Liao Antiatherosclerotic Effects of a Novel Synthetic Tissue-Selective Steroidal Liver X Receptor Agonist in Low-Density Lipoprotein Receptor-Deficient Mice J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 332 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Cybulsky Morphing the Topography of Atherosclerosis: An Unexpected Role for PECAM-1 Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 1887 - 1889. [Full Text] [PDF]
|
|
|
|
|
|
R. Goel, B. R. Schrank, S. Arora, B. Boylan, B. Fleming, H. Miura, P. J. Newman, R. C. Molthen, and D. K. Newman Site-Specific Effects of PECAM-1 on Atherosclerosis in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 1996 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Teupser, D. Kretzschmar, C. Tennert, R. Burkhardt, W. Wilfert, D. Fengler, R. Naumann, A. E. Sippel, and J. Thiery Effect of Macrophage Overexpression of Murine Liver X Receptor-{alpha} (LXR-{alpha}) on Atherosclerosis in LDL-Receptor Deficient Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 2009 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rampersaud, L. F. Bielak, A. Parsa, H. Shen, W. Post, K. A. Ryan, P. Donnelly, J. A. Rumberger, P. F. Sheedy II, P. A. Peyser, et al. The Association of Coronary Artery Calcification and Carotid Artery Intima-Media Thickness With Distinct, Traditional Coronary Artery Disease Risk Factors in Asymptomatic Adults Am. J. Epidemiol., November 1, 2008; 168(9): 1016 - 1023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gronros, J. Wikstrom, U. Brandt-Eliasson, G. B. Forsberg, M. Behrendt, G. I. Hansson, and L. M. Gan Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2046 - H2053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. H. Gijsen, J. J. Wentzel, A. Thury, F. Mastik, J. A. Schaar, J. C. H. Schuurbiers, C. J. Slager, W. J. van der Giessen, P. J. de Feyter, A. F. W. van der Steen, et al. Strain distribution over plaques in human coronary arteries relates to shear stress Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1608 - H1614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Kuo, J. M. Kalbfleisch, P. Rutherford, D. Gifford-Moore, X.-d. Huang, R. Christie, K. Hui, K. Gould, and M. Rekhter Chemical analysis of atherosclerotic plaque cholesterol combined with histology of the same tissue J. Lipid Res., June 1, 2008; 49(6): 1353 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Foteinos, Y. Hu, Q. Xiao, B. Metzler, and Q. Xu Rapid Endothelial Turnover in Atherosclerosis-Prone Areas Coincides With Stem Cell Repair in Apolipoprotein E-Deficient Mice Circulation, April 8, 2008; 117(14): 1856 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Mullick, K. Soldau, W. B. Kiosses, T. A. Bell III, P. S. Tobias, and L. K. Curtiss Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events J. Exp. Med., February 18, 2008; 205(2): 373 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Petrovan, Y. Yuan, and L. K. Curtiss Expression of the Lystbeige mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice J. Lipid Res., February 1, 2008; 49(2): 429 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Hastings, M. B. Simmers, O. G. McDonald, B. R. Wamhoff, and B. R. Blackman Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1824 - C1833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cheng, J. Zhang, A. Merched, L. Zhang, P. Zhang, L. Truong, A. M. Boriek, and J. Du Mechanical Stretch Inhibits Oxidized Low Density Lipoprotein-induced Apoptosis in Vascular Smooth Muscle Cells by Up-regulating Integrin {alpha}Vbeta3 and Stablization of PINCH-1 J. Biol. Chem., November 23, 2007; 282(47): 34268 - 34275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Korff, K. Aufgebauer, and M. Hecker Cyclic Stretch Controls the Expression of CD40 in Endothelial Cells by Changing Their Transforming Growth Factor-{beta}1 Response Circulation, November 13, 2007; 116(20): 2288 - 2297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Galkina and K. Ley Vascular Adhesion Molecules in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2292 - 2301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chang, D. Weiss, J. Suo, J. D. Vega, D. Giddens, W. R. Taylor, and H. Jo Bone Morphogenic Protein Antagonists Are Coexpressed With Bone Morphogenic Protein 4 in Endothelial Cells Exposed to Unstable Flow In Vitro in Mouse Aortas and in Human Coronary Arteries: Role of Bone Morphogenic Protein Antagonists in Inflammation and Atherosclerosis Circulation, September 11, 2007; 116(11): 1258 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Binder, K. Hartvigsen, and J. L. Witztum Promise of Immune Modulation to Inhibit Atherogenesis J. Am. Coll. Cardiol., August 7, 2007; 50(6): 547 - 550. [Full Text] [PDF]
|
|
|
|
|
|
L. E. Wagenknecht, C. D. Langefeld, B. I. Freedman, J. J. Carr, and D. W. Bowden A Comparison of Risk Factors for Calcified Atherosclerotic Plaque in the Coronary, Carotid, and Abdominal Aortic Arteries: The Diabetes Heart Study Am. J. Epidemiol., August 1, 2007; 166(3): 340 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Sung, A. Yee, S. G. Eskin, and L. V. McIntire Cyclic strain and motion control produce opposite oxidative responses in two human endothelial cell types Am J Physiol Cell Physiol, July 1, 2007; 293(1): C87 - C94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. S. Chatzizisis, A. U. Coskun, M. Jonas, E. R. Edelman, C. L. Feldman, and P. H. Stone Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling: Molecular, Cellular, and Vascular Behavior J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2379 - 2393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, K. Peppel, P. Sivashanmugam, E. S. Orman, L. Brian, S. T. Exum, and N. J. Freedman Expression of Tumor Necrosis Factor Receptor-1 in Arterial Wall Cells Promotes Atherosclerosis Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1087 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hartvigsen, C. J. Binder, L. F. Hansen, A. Rafia, J. Juliano, S. Horkko, D. Steinberg, W. Palinski, J. L. Witztum, and A. C. Li A Diet-Induced Hypercholesterolemic Murine Model to Study Atherogenesis Without Obesity and Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 878 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Oda, N. Tanaka, T. Arai, J. Araki, Y. Song, L. Zhang, A. Kuchiba, T. Hosoi, T. Shirasawa, M. Muramatsu, et al. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases Hum. Mol. Genet., March 15, 2007; 16(6): 592 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Orr, R. Stockton, M. B. Simmers, J. M. Sanders, I. J. Sarembock, B. R. Blackman, and M. A. Schwartz Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis J. Cell Biol., February 26, 2007; 176(5): 719 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Orr, M. H. Ginsberg, S. J. Shattil, H. Deckmyn, and M. A. Schwartz Matrix-specific Suppression of Integrin Activation in Shear Stress Signaling Mol. Biol. Cell, November 1, 2006; 17(11): 4686 - 4697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Curtiss Is Two out of Three Enough for ABCG1? Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2175 - 2177. [Full Text] [PDF]
|
|
|
|
|
|
M. Ohashi, M. S. Runge, F. M. Faraci, and D. D. Heistad MnSOD Deficiency Increases Endothelial Dysfunction in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2331 - 2336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Johnson, A. H. Baker, K. Oka, L. Chan, A. C. Newby, C. L. Jackson, and S. J. George Suppression of Atherosclerotic Plaque Progression and Instability by Tissue Inhibitor of Metalloproteinase-2: Involvement of Macrophage Migration and Apoptosis Circulation, May 23, 2006; 113(20): 2435 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Valgimigli, G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, P. Malagutti, E. Regar, P. de Jaegere, P. de Feyter, and P. W. Serruys Distance from the ostium as an independent determinant of coronary plaque composition in vivo: an intravascular ultrasound study based radiofrequency data analysis in humans Eur. Heart J., March 2, 2006; 27(6): 655 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Allred, E. J. Smart, and M. E. Wilson Estrogen Receptor-{alpha} Mediates Gender Differences in Atherosclerosis Induced by HIV Protease Inhibitors J. Biol. Chem., January 20, 2006; 281(3): 1419 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cheng, R. van Haperen, M. de Waard, L. C. A. van Damme, D. Tempel, L. Hanemaaijer, G. W. A. van Cappellen, J. Bos, C. J. Slager, D. J. Duncker, et al. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique Blood, December 1, 2005; 106(12): 3691 - 3698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P.W. Moos, N. John, R. Grabner, S. Nossmann, B. Gunther, R. Vollandt, C. D. Funk, B. Kaiser, and A. J.R. Habenicht The Lamina Adventitia Is the Major Site of Immune Cell Accumulation in Standard Chow-Fed Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2386 - 2391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. VanderLaan and C. A. Reardon Thematic review series: The Immune System and Atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis J. Lipid Res., May 1, 2005; 46(5): 829 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Orr, J. M. Sanders, M. Bevard, E. Coleman, I. J. Sarembock, and M. A. Schwartz The subendothelial extracellular matrix modulates NF-{kappa}B activation by flow: a potential role in atherosclerosis J. Cell Biol., April 11, 2005; 169(1): 191 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Getz Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis J. Lipid Res., January 1, 2005; 46(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sehayek and J. L. Breslow Plasma Plant Sterol Levels: Another Coronary Heart Disease Risk Factor? Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 5 - 6. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Teupser, S. Pavlides, M. Tan, J.-C. Gutierrez-Ramos, R. Kolbeck, and J. L. Breslow Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root PNAS, December 21, 2004; 101(51): 17795 - 17800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dai, M. R. Kaazempur-Mofrad, S. Natarajan, Y. Zhang, S. Vaughn, B. R. Blackman, R. D. Kamm, G. Garcia-Cardena, and M. A. Gimbrone Jr. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature PNAS, October 12, 2004; 101(41): 14871 - 14876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Reardon, E. R. Miller, L. Blachowicz, J. Lukens, C. J. Binder, J. L. Witztum, and G. S. Getz Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice J. Lipid Res., July 1, 2004; 45(7): 1347 - 1354. [Abstract] [Full Text] [PDF]
|
|